# Waters Corp: financial statements, quarterly

WAT · NYSE · CIK 1000697 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wat.md) · [Financials](/companies/wat/financials.md) · [Filings](/companies/wat/filings.md) · [Insiders](/companies/wat/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wat/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [712](/filings/0001193125-25-034579.md) | [819](/filings/0001193125-25-034579.md) | [637](/filings/0001193125-25-113274.md) | [709](/filings/0001193125-25-172087.md) | [740](/filings/0001193125-25-263533.md) | [873](/filings/0001193125-26-062604.md) | [662](/filings/0001193125-26-219487.md) | [771](/filings/0001193125-26-344691.md) | [800](/filings/0001193125-25-263533.md) | [932](/filings/0001193125-26-062604.md) | [1,267](/filings/0001193125-26-219487.md) | [1,645](/filings/0001193125-26-344691.md) |
| Cost of revenue | $m | [291](/filings/0001193125-25-034579.md) | [318](/filings/0001193125-25-034579.md) | [262](/filings/0001193125-26-062604.md) | [288](/filings/0001193125-26-062604.md) | [302](/filings/0001193125-26-062604.md) | [349](/filings/0001193125-26-062604.md) | [277](/filings/0001193125-26-062604.md) | [321](/filings/0001193125-26-062604.md) | [328](/filings/0001193125-26-062604.md) | [363](/filings/0001193125-26-062604.md) | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [42.0](/filings/0001193125-25-034579.md) | [44.4](/filings/0001193125-25-034579.md) | [44.6](/filings/0001193125-25-113274.md) | [46.2](/filings/0001193125-25-172087.md) | [45.3](/filings/0001193125-25-263533.md) | [46.9](/filings/0001193125-26-062604.md) | [47.0](/filings/0001193125-26-219487.md) | [49.0](/filings/0001193125-26-344691.md) | [53.6](/filings/0001193125-25-263533.md) | [46.9](/filings/0001193125-26-062604.md) | [96.0](/filings/0001193125-26-219487.md) | [122](/filings/0001193125-26-344691.md) |
| Selling, general and administrative | $m | [187](/filings/0001193125-25-034579.md) | [180](/filings/0001193125-25-034579.md) | [175](/filings/0001193125-25-113274.md) | [173](/filings/0001193125-25-172087.md) | [169](/filings/0001193125-25-263533.md) | [173](/filings/0001193125-26-062604.md) | [174](/filings/0001193125-26-219487.md) | [198](/filings/0001193125-26-344691.md) | [214](/filings/0001193125-25-263533.md) | [240](/filings/0001193125-26-062604.md) | [387](/filings/0001193125-26-219487.md) | [405](/filings/0001193125-26-344691.md) |
| Operating income | $m | [179](/filings/0001193125-25-034579.md) | [264](/filings/0001193125-25-034579.md) | [134](/filings/0001193125-25-113274.md) | [189](/filings/0001193125-25-172087.md) | [211](/filings/0001193125-25-263533.md) | [292](/filings/0001193125-26-062604.md) | [152](/filings/0001193125-26-219487.md) | [188](/filings/0001193125-26-344691.md) | [192](/filings/0001193125-25-263533.md) | [271](/filings/0001193125-26-062604.md) | [(47.0)](/filings/0001193125-26-219487.md) | [(86.0)](/filings/0001193125-26-344691.md) |
| Interest expense | $m | [30.4](/filings/0001193125-25-034579.md) | [30.7](/filings/0001193125-25-034579.md) | [25.5](/filings/0001193125-25-113274.md) | [23.7](/filings/0001193125-25-172087.md) | [21.4](/filings/0001193125-25-263533.md) | [19.0](/filings/0001193125-26-062604.md) | [14.0](/filings/0001193125-26-219487.md) | [15.0](/filings/0001193125-26-344691.md) | [26.6](/filings/0001193125-25-263533.md) | [14.3](/filings/0001193125-26-062604.md) | [48.0](/filings/0001193125-26-219487.md) | [60.0](/filings/0001193125-26-344691.md) |
| Income tax | $m | [18.6](/filings/0001193125-25-034579.md) | [21.4](/filings/0001193125-25-034579.md) | [12.7](/filings/0001193125-25-113274.md) | [26.7](/filings/0001193125-25-172087.md) | [32.1](/filings/0001193125-25-263533.md) | [45.6](/filings/0001193125-26-062604.md) | [22.0](/filings/0001193125-26-219487.md) | [31.0](/filings/0001193125-26-344691.md) | [21.2](/filings/0001193125-25-263533.md) | [39.0](/filings/0001193125-26-062604.md) | [(16.0)](/filings/0001193125-26-219487.md) | [(5.0)](/filings/0001193125-26-344691.md) |
| Net income | $m | [135](/filings/0001193125-25-034579.md) | [216](/filings/0001193125-25-034579.md) | [102](/filings/0001193125-25-113274.md) | [143](/filings/0001193125-25-172087.md) | [162](/filings/0001193125-25-263533.md) | [231](/filings/0001193125-26-062604.md) | [121](/filings/0001193125-26-219487.md) | [147](/filings/0001193125-26-344691.md) | [149](/filings/0001193125-25-263533.md) | [225](/filings/0001193125-26-062604.md) | [(72.0)](/filings/0001193125-26-219487.md) | [(136)](/filings/0001193125-26-344691.md) |
| Diluted EPS | $ per share | [2.27](/filings/0001193125-25-034579.md) | [3.65](/filings/0001193125-25-034579.md) | [1.72](/filings/0001193125-25-113274.md) | [2.40](/filings/0001193125-25-172087.md) | [2.71](/filings/0001193125-25-263533.md) | [3.88](/filings/0001193125-26-062604.md) | [2.03](/filings/0001193125-26-219487.md) | [2.47](/filings/0001193125-26-344691.md) | [2.50](/filings/0001193125-25-263533.md) | [3.77](/filings/0001193125-26-062604.md) | [(0.87)](/filings/0001193125-26-219487.md) | [(1.39)](/filings/0001193125-26-344691.md) |
| Basic EPS | $ per share | [2.28](/filings/0001193125-25-034579.md) | [3.66](/filings/0001193125-25-034579.md) | [1.73](/filings/0001193125-25-113274.md) | [2.41](/filings/0001193125-25-172087.md) | [2.72](/filings/0001193125-25-263533.md) | [3.90](/filings/0001193125-26-062604.md) | [2.04](/filings/0001193125-26-219487.md) | [2.47](/filings/0001193125-26-344691.md) | [2.50](/filings/0001193125-25-263533.md) | [3.78](/filings/0001193125-26-062604.md) | [(0.87)](/filings/0001193125-26-219487.md) | [(1.39)](/filings/0001193125-26-344691.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001193125-23-271909.md) | [0.4](/filings/0001193125-25-034579.md) | [0.3](/filings/0001193125-24-132558.md) | [0.3](/filings/0001193125-24-189466.md) | [0.3](/filings/0001193125-24-249126.md) | [0.3](/filings/0001193125-26-062604.md) | [0.4](/filings/0001193125-25-113274.md) | [0.4](/filings/0001193125-25-172087.md) | [0.5](/filings/0001193125-25-263533.md) | [0.6](/filings/0001193125-26-344691.md) | [0.5](/filings/0001193125-26-219487.md) | [0.5](/filings/0001193125-26-344691.md) |
| Current assets | $bn | [1.6](/filings/0001193125-23-271909.md) | [1.8](/filings/0001193125-25-034579.md) | [1.6](/filings/0001193125-24-132558.md) | [1.6](/filings/0001193125-24-189466.md) | [1.6](/filings/0001193125-24-249126.md) | [1.7](/filings/0001193125-26-062604.md) | [1.7](/filings/0001193125-25-113274.md) | [1.8](/filings/0001193125-25-172087.md) | [1.9](/filings/0001193125-25-263533.md) | [2.1](/filings/0001193125-26-344691.md) | [4.1](/filings/0001193125-26-219487.md) | [4.5](/filings/0001193125-26-344691.md) |
| Total assets | $bn | [4.5](/filings/0001193125-23-271909.md) | [4.6](/filings/0001193125-25-034579.md) | [4.5](/filings/0001193125-24-132558.md) | [4.4](/filings/0001193125-24-189466.md) | [4.5](/filings/0001193125-24-249126.md) | [4.6](/filings/0001193125-26-062604.md) | [4.6](/filings/0001193125-25-113274.md) | [4.7](/filings/0001193125-25-172087.md) | [4.9](/filings/0001193125-25-263533.md) | [5.1](/filings/0001193125-26-344691.md) | [24.5](/filings/0001193125-26-219487.md) | [24.8](/filings/0001193125-26-344691.md) |
| Current liabilities | $bn | [0.7](/filings/0001193125-23-271909.md) | [0.8](/filings/0001193125-25-034579.md) | [0.8](/filings/0001193125-24-132558.md) | [0.8](/filings/0001193125-24-189466.md) | [0.8](/filings/0001193125-24-249126.md) | [0.8](/filings/0001193125-26-062604.md) | [1.0](/filings/0001193125-25-113274.md) | [1.0](/filings/0001193125-25-172087.md) | [1.3](/filings/0001193125-25-263533.md) | [1.2](/filings/0001193125-26-344691.md) | [2.3](/filings/0001193125-26-219487.md) | [2.4](/filings/0001193125-26-344691.md) |
| Total liabilities | $bn | [3.6](/filings/0001193125-23-271909.md) | [3.5](/filings/0001193125-25-034579.md) | [3.3](/filings/0001193125-24-132558.md) | [3.0](/filings/0001193125-24-189466.md) | [2.9](/filings/0001193125-24-249126.md) | [2.7](/filings/0001193125-26-062604.md) | [2.6](/filings/0001193125-25-113274.md) | [2.6](/filings/0001193125-25-172087.md) | [2.5](/filings/0001193125-25-263533.md) | [2.5](/filings/0001193125-26-344691.md) | [9.2](/filings/0001193125-26-219487.md) | [9.6](/filings/0001193125-26-344691.md) |
| Long-term debt | $bn | [2.5](/filings/0001193125-23-271909.md) | [2.3](/filings/0001193125-25-034579.md) | [2.0](/filings/0001193125-24-132558.md) | [2.0](/filings/0001193125-24-189466.md) | [1.8](/filings/0001193125-24-249126.md) | [1.6](/filings/0001193125-26-062604.md) | [1.4](/filings/0001193125-25-113274.md) | [1.2](/filings/0001193125-25-172087.md) | [0.9](/filings/0001193125-25-263533.md) | [0.9](/filings/0001193125-26-344691.md) | [4.9](/filings/0001193125-26-219487.md) | [4.9](/filings/0001193125-26-344691.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [0.9](/filings/0001193125-24-249126.md) | [1.2](/filings/0001193125-26-062604.md) | [1.3](/filings/0001193125-25-172087.md) | [1.4](/filings/0001193125-25-263533.md) | [1.6](/filings/0001193125-25-263533.md) | [1.8](/filings/0001193125-26-344691.md) | [2.0](/filings/0001193125-26-344691.md) | [2.2](/filings/0001193125-26-344691.md) | [2.3](/filings/0001193125-25-263533.md) | [2.6](/filings/0001193125-26-344691.md) | [15.3](/filings/0001193125-26-344691.md) | [15.2](/filings/0001193125-26-344691.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [158 d](/filings/0001193125-24-249126.md) | [230 d](/filings/0001193125-26-062604.md) | [263](/filings/0001193125-25-113274.md) | [54.5 d](/filings/0001193125-25-172087.md) | [205 d](/filings/0001193125-25-263533.md) | [240 d](/filings/0001193125-26-062604.md) | [260](/filings/0001193125-26-219487.md) | [41.0 d](/filings/0001193125-26-344691.md) | [187 d](/filings/0001193125-25-263533.md) | [165 d](/filings/0001193125-26-062604.md) | [(3.0)](/filings/0001193125-26-219487.md) | [201 d](/filings/0001193125-26-344691.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | [26.0](/filings/0001193125-26-219487.md) | [23.0 d](/filings/0001193125-26-344691.md) | not reported | not reported | [39.0](/filings/0001193125-26-219487.md) | [48.0 d](/filings/0001193125-26-344691.md) |
| Share repurchases | $m | [0.7 d](/filings/0001193125-24-249126.md) | [(0.2) d](/filings/0001193125-26-062604.md) | [13.1](/filings/0001193125-25-113274.md) | [0.2 d](/filings/0001193125-25-172087.md) | [0.1 d](/filings/0001193125-25-263533.md) | [0.1 d](/filings/0001193125-26-062604.md) | [14.0](/filings/0001193125-26-219487.md) | [0.0 d](/filings/0001193125-26-344691.md) | [0.5 d](/filings/0001193125-25-263533.md) | [0.1 d](/filings/0001193125-26-062604.md) | [12.0](/filings/0001193125-26-219487.md) | [2.0 d](/filings/0001193125-26-344691.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | billions of shares | [0.1](/filings/0001193125-25-034579.md) | [0.1](/filings/0001193125-25-034579.md) | [0.1](/filings/0001193125-25-113274.md) | [0.1](/filings/0001193125-25-172087.md) | [0.1](/filings/0001193125-25-263533.md) | [0.1](/filings/0001193125-26-062604.md) | [59.7](/filings/0001193125-26-219487.md) | [59.7](/filings/0001193125-26-344691.md) | [0.1](/filings/0001193125-25-263533.md) | [0.1](/filings/0001193125-26-062604.md) | [82.1](/filings/0001193125-26-219487.md) | [98.2](/filings/0001193125-26-344691.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 98,248,111 at 2026-08-07, from the cover of the [10-Q filed 2026-08-11](/filings/0001193125-26-344691.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.